Moreover, conjugated with targeting moieties such as specific antibodies and ligands, metal-based NPs can be actively targeted to the disease sites by recognizing and binding to the corresponding membrane proteins (Meka et al., 2019
Our lawyers have learned that corporate defendants do not like to voluntarily turn over OSI information
The foundational characterization appeared in European Journal of Endocrinology in 1998, reporting selective agonism of the growth hormone secretagogue receptor type 1a (GHS-R1a) without significant elevation of ACTH, cortisol, prolactin, FSH, LH, or TSH, even at doses 200-fold above the GH-releasing ED50 in preclinical models
How long do the results of Fat Dissolving treatment last
Pancreatitis and pancreatic cancer: a case of the chicken or the egg
Withdraw the needle at the same angle used for insertion